Regulatory Rapporteur March 2008

<< back to list of Issues

Front Cover
Volume 5 Issue 3

In This Issue

  • New Regulation for Advanced Therapies
  • The work of the EMEA Innovation Task Force
  • Which RMS/Rapporteur?

Please login to view member only articles. Non-members may download the public articles.

TitleDownloadCategorySizeFile
Regulatory Rapporteur March 2008MembersFull Issue5MBPDF
UK Update: MHRA newsPublic204KBPDF
Editorial - Keeping pace with advanced therapiesMembers76KBPDF
EU Regulatory Intelligence: Updates January 2008Members77KBPDF
Fostering research and innovation: The EMEA Innovation Task Force activities and experience on innovationMembers158KBPDF
Germany as RMS or (Co-) Rapporteur – Agency and industry perspectivesMembers464KBPDF
Management Forum Course Abridged product licence applications for human useMembers270KBPDF
New Regulation for Advanced Therapy Medicinal ProductsMembers266KBPDF
News from the agencies Lack of resources for national regulatory authorities is major barrier to new generic medicines, says EGAMembers136KBPDF
The Exchange - Co-ordinated by Cambridge Regulatory Services LimitedMembers108KBPDF